Subtype B and low-risk group patients with a better prognosis demonstrated increased infiltration of activated memory CD4+ and CD8+ T cells, as well as gamma delta T cells, suggesting that these cells may positively contribute to the progression of HNSCC. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.